Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
EVO570
product1 mentionslast seen Nov 4, 2026
Oral, highly selective and potent VAV1 molecular glue degrader for autoimmune diseases.
Relationships 10
- Evommune, Inc.acquiresEVO57092% confidence1 source
- EVO570applies toRheumatoid Arthritis treatment90% confidence1 source
- Evommune, Inc.developsEVO57090% confidence1 source
- Hinova Pharmaceuticals Inc.developsEVO57090% confidence1 source
- Evommune, Inc.commercializesEVO57090% confidence1 source
- EVO570implementsVAV1 molecular glue degrader85% confidence1 source
- EVO570applies toautoimmune disease treatment85% confidence1 source
- EVO570competes withMRT-616075% confidence1 source
- EVO570competes withICP-53870% confidence1 source
- EVO570competes withHSK5663070% confidence1 source
Relationship
Hinova Pharmaceuticals Inc.developsEVO570
90% confidence1 supporting mentions
Either name opens that entity’s relationships.
Sources 1